(MENAFN- GlobeNewsWire - Nasdaq) ATLANTA, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces today that it will report third quarter financial results on October 26, 2023, prior to the market open.
Management will host a conference call at 9:00 AM ET on the same day, to review financial results and provide an update on corporate developments. Following management's formal remarks there will be a question-and-answer session.
Participants can register for the conference by navigating to
Please note that registered participants will receive their dial-in number upon registration and will dial directly into the call without delay. Those without Internet access or who are unable to pre-register may dial in by calling 1-844-839-2190 (domestic) or 1-412-717-9583 (international). All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to be joined into the Alimera Sciences call.
The conference call will also be available through live webcast at
And is also available through the company's website .
A webcast replay of the call will be available approximately one hour after the end of the call through January 26, 2024. The webcast replay can be accessed through the above links or by calling 1-877-344-7529 (domestic) or 1-412-317-0088 (international) and using access code #4883233. The telephonic replay will be available until November 9, 2023.
About Alimera Sciences, Inc.
Alimera Sciences a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit .
For press inquiries:
Jules Abraham
for Alimera Sciences
917-885-7378
| For investor inquiries:
Scott Gordon
for Alimera Sciences
|
![]()
Tags $ALIM
MENAFN16102023004107003653ID1107248766
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.